Literature DB >> 17999358

Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4.

Nadege Bondurand1, Florence Dastot-Le Moal, Laure Stanchina, Nathalie Collot, Viviane Baral, Sandrine Marlin, Tania Attie-Bitach, Irina Giurgea, Laurent Skopinski, William Reardon, Annick Toutain, Pierre Sarda, Anis Echaieb, Marilyn Lackmy-Port-Lis, Renaud Touraine, Jeanne Amiel, Michel Goossens, Veronique Pingault.   

Abstract

Waardenburg syndrome (WS) is an auditory-pigmentary disorder that exhibits varying combinations of sensorineural hearing loss and abnormal pigmentation of the hair and skin. Depending on additional symptoms, WS is classified into four subtypes, WS1-WS4. Absence of additional features characterizes WS2. The association of facial dysmorphic features defines WS1 and WS3, whereas the association with Hirschsprung disease (aganglionic megacolon) characterizes WS4, also called "Waardenburg-Hirschsprung disease." Mutations within the genes MITF and SNAI2 have been identified in WS2, whereas mutations of EDN3, EDNRB, and SOX10 have been observed in patients with WS4. However, not all cases are explained at the molecular level, which raises the possibility that other genes are involved or that some mutations within the known genes are not detected by commonly used genotyping methods. We used a combination of semiquantitative fluorescent multiplex polymerase chain reaction and fluorescent in situ hybridization to search for SOX10 heterozygous deletions. We describe the first characterization of SOX10 deletions in patients presenting with WS4. We also found SOX10 deletions in WS2 cases, making SOX10 a new gene of WS2. Interestingly, neurological phenotypes reminiscent of that observed in WS4 (PCWH syndrome [peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, WS, and Hirschsprung disease]) were observed in some WS2-affected patients with SOX10 deletions. This study further characterizes the molecular complexity and the close relationship that links the different subtypes of WS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17999358      PMCID: PMC2276340          DOI: 10.1086/522090

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  75 in total

Review 1.  Waardenburg syndrome.

Authors:  A P Read; V E Newton
Journal:  J Med Genet       Date:  1997-08       Impact factor: 6.318

Review 2.  From head to toes: the multiple facets of Sox proteins.

Authors:  M Wegner
Journal:  Nucleic Acids Res       Date:  1999-03-15       Impact factor: 16.971

Review 3.  Endothelin receptor-mediated signaling in hirschsprung disease.

Authors:  A Chakravarti
Journal:  Hum Mol Genet       Date:  1996-03       Impact factor: 6.150

4.  SOX10 mutations in patients with Waardenburg-Hirschsprung disease.

Authors:  V Pingault; N Bondurand; K Kuhlbrodt; D E Goerich; M O Préhu; A Puliti; B Herbarth; I Hermans-Borgmeyer; E Legius; G Matthijs; J Amiel; S Lyonnet; I Ceccherini; G Romeo; J C Smith; A P Read; M Wegner; M Goossens
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

5.  A molecular analysis of the yemenite deaf-blind hypopigmentation syndrome: SOX10 dysfunction causes different neurocristopathies.

Authors:  N Bondurand; K Kuhlbrodt; V Pingault; J Enderich; M Sajus; N Tommerup; M Warburg; R C Hennekam; A P Read; M Wegner; M Goossens
Journal:  Hum Mol Genet       Date:  1999-09       Impact factor: 6.150

6.  The Sox10(Dom) mouse: modeling the genetic variation of Waardenburg-Shah (WS4) syndrome.

Authors:  E M Southard-Smith; M Angrist; J S Ellison; R Agarwala; A D Baxevanis; A Chakravarti; W J Pavan
Journal:  Genome Res       Date:  1999-03       Impact factor: 9.043

7.  Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis.

Authors:  S C Yau; M Bobrow; C G Mathew; S J Abbs
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

8.  Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease.

Authors:  T Attié; A Pelet; P Edery; C Eng; L M Mulligan; J Amiel; L Boutrand; C Beldjord; C Nihoul-Fékété; A Munnich
Journal:  Hum Mol Genet       Date:  1995-08       Impact factor: 6.150

9.  Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome).

Authors:  P Edery; T Attié; J Amiel; A Pelet; C Eng; R M Hofstra; H Martelli; C Bidaud; A Munnich; S Lyonnet
Journal:  Nat Genet       Date:  1996-04       Impact factor: 38.330

10.  A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome).

Authors:  R M Hofstra; J Osinga; G Tan-Sindhunata; Y Wu; E J Kamsteeg; R P Stulp; C van Ravenswaaij-Arts; D Majoor-Krakauer; M Angrist; A Chakravarti; C Meijers; C H Buys
Journal:  Nat Genet       Date:  1996-04       Impact factor: 38.330

View more
  89 in total

1.  Disrupted SOX10 function causes spongiform neurodegeneration in gray tremor mice.

Authors:  Sarah R Anderson; Inyoul Lee; Christine Ebeling; Dennis A Stephenson; Kelsey M Schweitzer; David Baxter; Tara M Moon; Sarah LaPierre; Benjamin Jaques; Derek Silvius; Michael Wegner; Leroy E Hood; George Carlson; Teresa M Gunn
Journal:  Mamm Genome       Date:  2014-11-16       Impact factor: 2.957

Review 2.  Sox proteins in melanocyte development and melanoma.

Authors:  Melissa L Harris; Laura L Baxter; Stacie K Loftus; William J Pavan
Journal:  Pigment Cell Melanoma Res       Date:  2010-04-22       Impact factor: 4.693

3.  The armadillo repeat-containing protein, ARMCX3, physically and functionally interacts with the developmental regulatory factor Sox10.

Authors:  Zhongming Mou; Andrew R Tapper; Paul D Gardner
Journal:  J Biol Chem       Date:  2009-03-20       Impact factor: 5.157

4.  Analysis of early human neural crest development.

Authors:  Erin Betters; Ying Liu; Anders Kjaeldgaard; Erik Sundström; Martín I García-Castro
Journal:  Dev Biol       Date:  2010-05-15       Impact factor: 3.582

5.  A novel SOX10 mutation in a patient with PCWH who developed hypoxic-ischemic encephalopathy after E. coli sepsis.

Authors:  Alexandra Unzicker; Veronique Pingault; Thomas Meyer; Stephan Rauthe; Ansgar Schütz; Steffen Kunzmann
Journal:  Eur J Pediatr       Date:  2011-08-06       Impact factor: 3.183

Review 6.  Development and developmental disorders of the enteric nervous system.

Authors:  Florian Obermayr; Ryo Hotta; Hideki Enomoto; Heather M Young
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-12-11       Impact factor: 46.802

7.  Is it Usher syndrome? Collaborative diagnosis and molecular genetics of patients with visual impairment and hearing loss.

Authors:  Heather A Stiff; Christina M Sloan-Heggen; Ashley Ko; Wanda L Pfeifer; Diana L Kolbe; Carla J Nishimura; Kathy L Frees; Kevin T Booth; Donghong Wang; Amy E Weaver; Hela Azaiez; John Kamholz; Richard J H Smith; Arlene V Drack
Journal:  Ophthalmic Genet       Date:  2020-04-13       Impact factor: 1.803

8.  Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage.

Authors:  Markus Finzsch; Silke Schreiner; Tatjana Kichko; Peter Reeh; Ernst R Tamm; Michael R Bösl; Dies Meijer; Michael Wegner
Journal:  J Cell Biol       Date:  2010-05-10       Impact factor: 10.539

9.  Novel MLPA procedure using self-designed probes allows comprehensive analysis for CNVs of the genes involved in Hirschsprung disease.

Authors:  Avencia Sánchez-Mejías; Rocio Núñez-Torres; Raquel M Fernández; Guillermo Antiñolo; Salud Borrego
Journal:  BMC Med Genet       Date:  2010-05-11       Impact factor: 2.103

10.  A curated online resource for SOX10 and pigment cell molecular genetic pathways.

Authors:  Laura L Baxter; R Travis Moreland; Anh-Dao Nguyen; Tyra G Wolfsberg; William J Pavan
Journal:  Database (Oxford)       Date:  2010-10-25       Impact factor: 3.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.